Position history for FRANKLIN RESOURCES INC's holdings in REGENERON PHARMACEUTICALS
FRANKLIN RESOURCES INC holds 2.7M shares of REGN (REGENERON PHARMACEUTICALS), worth $2.1B as of 2026-Q1. The position was increased (+6.3% shares). REGN represents 0.5% of FRANKLIN RESOURCES INC's portfolio.
Current Value
$2.1B
Current Shares
2.7M
Total Value Change
+$81.9M
Total Shares Change
+798,969
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.7M |
+6.3% |
| $2.1B |
| 0.5% |
| $766.66 |
48 |
| 2025-Q4 | Increased | 2.6M | +4.4% | $2B | 0.5% | $773.94 | 40 |
| 2025-Q3 | Increased | 2.5M | +6.0% | $1.4B | 0.3% | $560.05 | 41 |
| 2025-Q2 | Increased | 2.3M | +1.6% | $1.2B | 0.3% | $519.56 | 39 |
| 2025-Q1 | Increased | 2.3M | +11.3% | $1.4B | 0.4% | $634.66 | 42 |
| 2024-Q4 | Increased | 2M | +7.9% | $1.5B | 0.4% | $698.71 | 41 |
| 2024-Q3 | Decreased | 1.9M | -1.4% | $1.9B | 0.5% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 1.9M | +13.5% | $2B | 0.6% | $1,045.23 | 51 |